Cost-effectiveness of oral versus injectable disease modifying therapies in relapsing multiple sclerosis: a systematic review analysis
Abstract Background Multiple sclerosis (MS) is a chronic and progressive neurological autoimmune disease that affects the central nervous system. There are two types of drugs used to treat this disease: injectable and oral drugs. The present study aimed at systematically reviewing the cost effective...
Auteurs principaux: | , , , |
---|---|
Format: | Article |
Langue: | English |
Publié: |
BMC
2024-10-01
|
Collection: | BMC Health Services Research |
Sujets: | |
Accès en ligne: | https://doi.org/10.1186/s12913-024-11800-8 |